Discussion In real-world clinical use of remote glucose monitoring in a large, diverse, community-based population of patients newly diagnosed with type 2 diabetes, patients starting with a baseline HbA1c >8% had an absolute 0.93% greater improvement in their HBA1c value improvement compared to non-users, with improvements that did not reach statistical significance in in patients with lower HbA1c at baseline.
← all excerpts
Remote glucose monitoring and HbA1c improvement among persons with newly diagnosed diabetes mellitus type 2: A multi-center community-based study.
1
—
—